Angus Jones

Has grant

Associate Clinical Professor

University of Exeter

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Angus Jones is an Associate Clinical Professor at the University of Exeter, UK. His research focuses on diabetes management, particularly concerning glycaemic control, predictors of diabetes onset in youth, and the effectiveness of various anti-hyperglycaemic therapies. He has contributed significantly to understanding type 2 diabetes treatment outcomes and the impact of clinical prediction models in this field.

Recent Grants

Grant: Close

Determining the impact of C-peptide testing in possible type 1 diabetes

Open Date: 2023-03-01

Close Date: 2024-03-01

Grant: Close

Precision treatment of type 2 diabetes: understanding biomarker predictors of differential response to oral glucose lowering therapies in the TRIMASTER crossover trial

Open Date: 2022-11-01

Close Date: 2024-05-01

Grant: Close

Using genetics to better diagnose and treat adult-onset T1D in multi-ethnic US population

Open Date: 2022-09-01

Close Date: 2025-08-01

Grant: Close

Developing clinical calculators to improve classification of atypical diabetes and diabetes in under-represented populations

Open Date: 2022-05-01

Close Date: 2022-05-01

Grant: Close

Developing a decision support tool to enable precision treatment of type 2 diabetes

Open Date: 2022-03-01

Close Date: 2025-03-01

Articles (25)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (22)

Jakob Nissen

Assistant Professor

University of Copenhagen

DENMARK

Angus Jones

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (25)

Glycated albumin and fructosamine do not improve accuracy of glycaemic control assessment in patients with conditions reported to affect HbA1c reliability

The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth

The impact of prolonged walking on fasting plasma glucose in type 2 diabetes: A randomised controlled crossover study

Treatment outcomes with oral anti‐hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population‐based cohort study

A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study

Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach

Autoantibodies to Truncated GAD(96-585) Antigen Stratify Risk of Early Insulin Requirement in Adult-Onset Diabetes

Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes

The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1

Switching to reusable cartridge insulin pens can reduce National Health Service costs while delivering environmental benefits

Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562–570

Impact of haemoglobin variants on the diagnostic sensitivity of glycated haemoglobin (HbA1c) assay methodologies in sub-Saharan Africa: a laboratory-based method validation study.

Long-term outcomes after severe childhood malnutrition in adolescents in Malawi (LOSCM): a prospective observational cohort study.

Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study

Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models

Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

Correction to: The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis

HbA1c screening for the diagnosis of diabetes. Reply to Brož J, Brabec M, Krollová P et al [letter]

Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes

The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis

The phenotype of type 1 diabetes in sub-Saharan Africa

The challenges of identifying and studying type 1 diabetes in adults

Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation

Collaborators (22)

Jakob Nissen

Mathias Uhlen

Jochen M Schwenk

Tue Hansen

Ewan Pearson

Jack Bowden

Oluf Pedersen

Nisha Shah

Henry Webel

Anna Long

Torben Hansen

Mark Haid

Federico De Masi

Tarja Kokkola

Fiona Warren

Anders Gorm Pedersen

Ines Barroso

Colin Dayan

Henrik Vestergaard

Agnete Troen Lundgaard

Andrew Hattersley

John Dennis

Make your next move.